LeanTaaS Named a ‘Flagship Vendor’ for Operational Excellence in Chilmark Research Market Trends Report on Augmented Intelligence for Healthcare Operations
SANTA CLARA, Calif.--(BUSINESS WIRE)--Dec 21, 2021--
LeanTaaS, Inc., a Silicon Valley software innovator that increases patient access and transforms operational performance for healthcare providers, today announced it has been named as a Flagship Vendor for Operational Excellence / Asset Optimization in the latest report from Chilmark Research, Augmented Intelligence for Healthcare Operations. This new 2021 report highlights 10 enterprise AI4Ops solutions, which include all activities linked to healthcare operations (hospital operations, discharge planning, revenue cycle management, and supply chains). This emerging category of the industry is experiencing explosive growth, with a CAGR of 40% forecast over the next five years as mature solutions like those from LeanTaaS effectively demonstrate the significant ROI of their client implementations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211221005007/en/
Chilmark Research Report, “Augmented Intelligence for Healthcare Operations,” cites LeanTaaS as the leader in both market execution and product capabilities among all rated vendors. (Graphic: Business Wire)
LeanTaaS is featured in the Hospital Operations & Asset Optimization category of the report, where Chilmark highlights the company’s strengths, including LeanTaaS’s competitive edge over tools created by EHR vendors and impressive use cases at the majority of the top 20 health systems in the U.S. LeanTaaS received the highest marks in the report, ranking as the leader in both market execution and product capabilities among all rated vendors.
Select highlights from the report can be found in this excerpt and include:
- One of the top market differentiators for LeanTaaS is its significant demonstrable ROI at 120+ health systems across 40+ states;
- Another key differentiator for LeanTaaS is its ability to match variable supply and variable demand for assets in a manner that EHRs cannot accomplish;
- LeanTaaS’s iQueue suite of solutions have both a market-leading pricing model and implementation strategy;
- LeanTaaS’s clients, on average, recoup investment in 3-6 months post-implementation;
- The iQueue suite of solutions is deployed remotely and relatively easy to implement without the need for significant hospital IT resources nor vendor consulting staff and fees; and
- The platform is highly scalable and offers impressive ROI in a short time duration. LeanTaaS offers a money back guarantee, evidence of a mature pricing model. It has been an invaluable tool during the COVID-19 crisis with managing beds, surgical backlogs, and staffing optimization.
When asked about the findings of the research, author and lead analyst Jody Ranck had this to say about the current market trends, “While there has been a great deal of focus on virtual care and the pandemic, a lesser-known story is the significant role of AI for operations platforms in helping hospitals and providers meet the financial, scheduling, and supply chain challenges wrought by COVID-19. The solutions available today are surprisingly more mature than many other application areas for AI and machine learning.”
LeanTaaS’s AI and ML based solutions have now been deployed in more than 475 hospitals across the U.S., including 40% of the top 25 health systems in the country, based on net patient revenue. These hospitals use LeanTaaS’s iQueue platform to optimize capacity utilization in infusion centers, operating rooms, and inpatient beds. iQueue for Infusion Centers is used by 9,900+ chairs across 485+ infusion sites including 80% of the National Comprehensive Cancer Network (NCCN). iQueue for Operating Rooms is used by more than 2,400 ORs across 43 health systems to perform more surgical cases during business hours, increase competitiveness in the marketplace, and improve the patient experience. LeanTaaS’s newest product, iQueue for Inpatient Beds, is now live at 15 hospitals across three major academic healthcare systems (totaling 4,002 inpatient beds) to help address inpatient capacity bottlenecks and increase confidence in managing unplanned variability.
“We’ve experienced an impressive +40% growth during the pandemic period thanks to our mission of improving patient access and operational performance by optimizing costly, constrained healthcare resources, which has been a top priority for hospital and health system executives in today’s challenging healthcare environment,” said Mohan Giridharadas, LeanTaaS founder and CEO. “This report represents the breadth of LeanTaaS’s capabilities, features, and incredible partners we’ve worked closely with throughout the past decade and, more recently, the past two years.”
The report comes on the heels of recent momentum including a second successful Transform Hospital Operations Virtual Summit and two major award wins with CB Insights and BIG Award for Business. Additionally, LeanTaaS recently announced details about its significant growth during the pandemic period, demonstrating heightened need to provide tools that reduce costs and transform the healthcare experience for providers and patients alike.
The Augmented Intelligence for Healthcare Operations report is available to subscribers of the Chilmark Advisory Service or may be purchased separately. For more information, visit the sales page or send direct inquiries to John Moore III.
Founded in 2007, Chilmark Research is a global research and advisory firm that is solely focused on the market for healthcare IT solutions. Everything we do is based on our core belief that healthcare information technology (HIT) plays a crucial role in improving the quality and efficiency of care. We foster the effective adoption, deployment, and use of HIT by providing objective, high-quality research into technologies with the greatest potential to improve care. This laser-sharp focus allows us to provide our clients with the most in-depth and accurate research on the critical technology and adoption trends occurring throughout the healthcare sector.
LeanTaaS provides software solutions that combine lean principles, predictive, prescriptive analytics, and machine learning to transform hospital and infusion center operations. The company’s software is being used by over 120 health systems across the nation, which all rely on the iQueue cloud-based solutions to increase patient access, decrease wait times, reduce healthcare delivery costs, and improve revenue. LeanTaaS is based in Santa Clara, California, and Charlotte, North Carolina. For more information about LeanTaaS, please visit https://leantaas.com/, and connect on Twitter, Facebook and LinkedIn.
LeanTaaS and iQueue are trademarks of LeanTaaS. All other brand names and product names are trademarks or registered trademarks of their respective companies.
View source version on businesswire.com:https://www.businesswire.com/news/home/20211221005007/en/
CONTACT: LeanTaaS Media
KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA
INDUSTRY KEYWORD: DATA MANAGEMENT HEALTH TECHNOLOGY HOSPITALS MANAGED CARE SOFTWARE GENERAL HEALTH
SOURCE: LeanTaaS, Inc.
Copyright Business Wire 2021.
PUB: 12/21/2021 11:00 AM/DISC: 12/21/2021 11:01 AM